Xueyan Wang
Impact in
- Hepatology top 2%
- Hepatitis C virus research
Papers in
- Epidemiology 32
- Hepatitis B Virus Studies 24
- Liver Disease Diagnosis and Treatment 14
- Co-authors
- Zhongyi Jiang (5 shared papers)Jiafu Shi (5 shared papers)Pingping Han (4 shared papers)Yang Chen (1 shared paper)Xiaoli Wang (1 shared paper)Yanjun Jiang (1 shared paper)Shaohua Zhang (1 shared paper)Zhong‐Liao Fang (22 shared papers)
- Journals
- Journal of Medical Virology (5 papers)PLoS ONE (3 papers)Scientific Reports (2 papers)Molecular Cytogenetics (2 papers)Journal of General Virology (2 papers)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Xueyan Wang
101 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 132
- Hepatology 394
- Process Chemistry and Technology 93
- Renewable Energy, Sustainability and the Environment 248
- Epidemiology 487
- Biological Psychiatry 35
Countries citing papers authored by Xueyan Wang
This map shows the geographic impact of Xueyan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueyan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueyan Wang more than expected).
Fields of papers citing papers by Xueyan Wang
This network shows the impact of papers produced by Xueyan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueyan Wang. The network helps show where Xueyan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xueyan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 330 | |
| 2 | 2015 | 217 | |
| 3 | 2003 | 105 | |
| 4 | 2012 | 98 | |
| 5 | 2010 | 89 | |
| 6 | 2008 | 89 | |
| 7 | 2008 | 86 | |
| 8 | 2017 | 75 | |
| 9 | 2009 | 59 | |
| 10 | 2015 | 58 | |
| 11 | 2003 | 33 | |
| 12 | 2015 | 33 | |
| 13 | 2014 | 31 | |
| 14 | 2016 | 30 | |
| 15 | 2017 | 30 | |
| 16 | 2010 | 29 | |
| 17 | 2016 | 28 | |
| 18 | 1996 | 26 | |
| 19 | 2012 | 25 | |
| 20 | Genome-scale CRISPR activation screening identifies a role of ELAVL2-CDKN1A axis in paclitaxel resistance in esophageal squamous cell carcinoma. | 2019 | 24 |
About Xueyan Wang
Xueyan Wang is a scholar working on Epidemiology, Molecular Biology, Hepatology, Genetics and Immunology, having authored 117 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (24 papers), Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (14 papers), Hepatitis Viruses Studies and Epidemiology (6 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (5 papers), Nanoparticle-Based Drug Delivery (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Polymer Surface Interaction Studies (4 papers). The work is most often cited by research in Hepatology (394 citations), Process Chemistry and Technology (93 citations), Renewable Energy, Sustainability and the Environment (248 citations), Epidemiology (487 citations) and Biological Psychiatry (35 citations). Xueyan Wang has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Zhongyi Jiang, Jiafu Shi, Pingping Han, Yang Chen, Xiaoli Wang, Yanjun Jiang, Shaohua Zhang, Zhong‐Liao Fang, Tim J. Harrison and Hongsong Chen. Their work appears in journals such as Journal of Medical Virology, PLoS ONE, Scientific Reports, Molecular Cytogenetics and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.